Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Fibrinogen versus placebo during craniosynostosis surgery in children
NL-OMON28896Active, not recruiting
- Sponsor
- Erasmus MC
- Start
- Sep 2011
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Randomised, double-blind trial in Craniosynostosis comparing Fibrinogen concentrate with Placebo (2 arms). Primary endpoint: Perioperative blood loss. Started Sep 2011; status: active, not recruiting.
02
Drugs
Fibrinogen human
03
Conditions
Craniosynostosis
Beyond the preview
Go deeper on NL-OMON28896.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON28896.